Long-term culture of primary porcine mature hepatocytes in the medium supplemented with ascorbic acid 2-phosphate

Yohichi Kumaki, Iku Kumaki, Xiaomei Guo, Weilin Shang, Toshie Koyama, Ai Okamura, Yoshiaki Shiba, Toshiyuki Mukaiyama, Noriko Sasaki, Makoto Kodama

.

DOI: 10.4236/ns.2010.211153                

Abstract

In this study, the effect of ascorbic acid 2-phosphate (Asc2P) was tested on porcine and rat mature hepatocytes in vitro. a). Asc2P increased the porcine, but not rat, albumin secretion and mRNA expression. The enhancing effect of Asc2P on porcine C/EBP alpha mRNA was observed in porcine mature hepatocytes. These data suggested that Asc2P played an important role in the regulation of porcine albumin mRNA level. b). The enhancing effect of Asc2P on ammonium metabolic activity was also observed in porcine, but not rat, mature hepatocytes. The porcine ornithine transcarbamylase (OTC) and arginase mRNAs were augmented by Asc2P, indicating that Asc2P had a direct effect on the urea cycle. c). The porcine collagen type I and type III mRNA, but not type XII mRNA, were detected as well, sugessting that Asc2P did not have the effect on the non-parenchymal hepatocytes to induce collagen type I and III mRNA expression. d). Our RT-PCR analysis demonstrated that the porcine hepatocytes expressed the sodium-ascorbate co-transporters SVCT1 and SVCT2, however, the intensities of porcine sodium-ascorbate co-transporters SVCT1 and SVCT2 bands were not changed markedly. These findings indicated that the Asc2P had no effect on SVCT1 and SVCT2 mRNA expression. e). The enhancing effect of Asc2P on porcine albumin mRNA was inhibited by staurosporine, a portein kinase inhibitor. We conclude that the enhanced albumin mRNA by Asc2P might be due to activation of tyrosine protein kinase and/or PKC and the Asc2P enhanced porcine albumin mRNA mainly at the transcriptional step.

Keywords

Albumin Secretion; Ammonium Metabolic Activity; Ascorbic Acid 2-Phosphate; Porcine Hepatocytes; Reverse Transcriptase-Polymerase Chain Reaction

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Tateno, C. and Yoshizato, K. (1999) Long-term cultivation of adult rat hepatocytes that undergo multiple cell divisions and express normal parenchymal phenotypes. American Journal of Pathology, 148, 383-392.
[2]	Tateno, C. and Yoshizato, K. (1999) Growth potential and differentiation capacity of adult rat hepatocytes in vitro. Wound Repair Regen, 7, 36-44.
[3]	Yamasaki, C., Tateno, C., Aratani, A., Ohnishi, C., Katayama, S., Kohashi, T., Hino, H., Marusawa, H., Asahara, T. and Yoshizato, K. (2006) Growth and differentiation of colony-forming human hepatocytes in vitro. Journal of Hepatology, 44, 749-757.
[4]	Katsura, N., Ikai, I., Mitaka, T., Shiotani, T., Yamanokuchi, S., Sugimoto, S., Kanazawa, A., Terajima, H., Mochizuki, Y. and Yamaoka, Y. (2002) Long-term culture of primary human hepatocytes with preservation of proliferative capacity and differentiated functions. The Journal of surgical research, 106, 115-123.
[5]	Aden, D.P., Fogel, A., Plotkin, S., Damjanov, I. and Knowles, B.B. (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature, 282, 615-616.
[6]	Knowles, B.B., Howe, C.C. and Aden, D.P. (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science, 209, 497-499.
[7]	Weinstock, J. and Baldwin, G.S. (1988) Nucleotide sequence of porcine liver albumin. Nucleic Acids Research, 16, 9045.
[8]	Sargent, T.D., Yang, M. and Bonner, J. (1981) Nucleotide sequence of cloned rat serum albumin messenger RNA. Proceedings of National Academy of Science of the United States of America, 78, 243-246.
[9]	Sabath, D.E., Broome, H.E. and Prystowsky, M.B. (1990) Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene, 91, 185-191.
[10]	Ding, S.T., McNeel, R.L. and Mersmann, H.J. (1999) Expression of porcine adipocyte transcripts: tissue distribution and differentiation in vitro and in vivo. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 123, 307-318.
[11]	Koger, J.B., Howell, R.G., Kelly, M. and Jones, E.E. (1994) Purification and properties of porcine liver ornithine transcarbamylase. Archives of Biochemistry and Biophysics, 309, 293-299.
[12]	Haraguchi, Y., Takiguchi, M., Amaya, Y., Kawamoto, S., Matsuda, I. and Mori, M. (1987) Molecular cloning and nucleotide sequence of cDNA for human liver arginase. Proceedings of National Academy of Science of the United States of America, 84, 412-415.
[13]	Clark, A.G., Rohrbaugh, A.L., Otterness, I. and Kraus, V.B. (2002) The effects of ascorbic acid on cartilage metabolism in guinea pig articular cartilage explants. Matrix Biology, 21, 175-184.
[14]	Mitaka, T., Sattler, C.A., Sattler, G.L., Sargent, L.M. and Pitot, H.C. (1991) Multiple cell cycles occur in rat hepatocytes cultured in the presence of nicotinamide and epidermal growth factor. Hepatology, 13, 21-30.
[15]	Mitaka, T., Mikami, M., Sattler, G.L., Pitot, H.C. and Mochizuki, Y. (1992) Small cell colonies appear in the primary culture of adult rat hepatocytes in the presence of nicotinamide and epidermal growth factor. Hepatology, 16, 440-447.
[16]	Mitaka, T., Kojima, T., Mizuguchi, T. and Mochizuki, Y. (1995) Growth and maturation of small hepatocytes isolated from adult rat liver. Biochemical and biophysical research communications, 214, 310-317.
[17]	Mitaka, T., Mizuguchi, T., Sato, F., Mochizuki, C. and Mochizuki, Y. (1998) Growth and maturation of small hepatocytes. Journal of Gastroenterology Hepatology, 13, S70-77.
[18]	Hino, H., Tateno, C., Sato, H., Yamasaki, C., Katayama, S., Kohashi, T., Aratani, A., Asahara, T., Dohi, K. and Yoshizato, K. (1999) A long-term culture of human hepatocytes which show a high growth potential and express their differentiated phenotypes. Biochemical and Biophysical Research Communications, 256, 184-191.
[19]	Babiss, L.E., Herbst, R.S., Bennett, A.L. and Darnell, Jr., J.E. (1987) Factors that interact with the rat albumin promoter are present both in hepatocytes and other cell types. Genes Development, 1, 256-267.
[20]	Cereghini, S., Raymondjean, M., Carranca, A.G., Herbomel, P. and Yaniv, M. (1987) Factors involved in control of tissue-specific expression of albumin gene. Cell, 50, 627-638.
[21]	Lichtsteiner, S., Wuarin, J. and Schibler, U. (1987) The interplay of DNA-binding proteins on the promoter of the mouse albumin gene. Cell, 51, 963-973.
[22]	Liu, J.K., DiPersio, C.M. and Zaret, K.S. (1991) Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. Molecular Cell Biology, 11, 773-784.
[23]	Herbst, R.S., Friedman, N., Darnell, J.E. and Babiss, Jr., L.E. (1989) Positive and negative regulatory elements in the mouse albumin enhancer. Proceedings of National Academy of Science of the United States of America, 86, 1553-1557.
[24]	Pontoglio, M., Barra, J., Hadchouel, M., Doyen, A., Kress, C., Bach, J.P., Babinet, C. and Yaniv, M. (1996) Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell, 84, 575-585.
[25]	Samadani, U. and Costa, R.H. (1996) The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression. Molecular Cell Biology, 16, 6273-6284.
[26]	Mitaka, T., Sato, F., Mizuguchi, T., Yokono, T. and Mochizuki, Y. (1999) Reconstruction of hepatic organoid by rat small hepatocytes and hepatic nonparenchymal cells. Hepatology, 29, 111-125.
[27]	Sasaki, K., Kitaguchi, Y., Fukuda, T. and Aoyagi, Y. (2000) Ascorbic acid supplementation to primary culture of chicken hepatocytes with non-serum medium. The International Journal of Biochemistry & Cell Biology, 32, 967-973.
[28]	Seki, J., Ikeda, R. and Hoshino, H. (1996) Dimethyl sulfoxide and related polar compounds enhance infection of human T cells with HIV-1 in vitro. Biochemical and biophysical research communications, 227, 724-729.
[29]	Stamatoglou, S.C. and Hughes, R.C. (1994) Cell adhesion molecules in liver function and pattern formation. The FASEB Journal, 8, 420-427.
[30]	Bissell, D.M., Arenson, D.M., Maher, J.J. and Roll, F.J. (1987) Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. The Journal of Clinical Investigation, 79, 801-812.
[31]	Tobe, S., Takei, Y., Kobayashi, K. and Akaike, T. (1992) Receptor-mediated formation of multilayer aggregates of primary cultured adult rat hepatocytes on lactose-substituted polystyrene. Biochemical and Biophysical Research Communications, 184, 225-230.
[32]	Sudhakaran, P.R., Stamatoglou, S.C. and Hughes, R.C. (1986) Modulation of protein synthesis and secretion by substratum in primary cultures of rat hepatocytes. Experimental Cell Research, 167, 505-516.
[33]	Bentley, S.A. (1982) Collagen synthesis by bone marrow stromal cells: A quantitative study. British Journal of Haematology, 50, 491-497.
[34]	Vuorio, E. and de Crombrugghe, B. (1990) The family of collagen genes. The Annual Review of Biochemistry, 59, 837-872.
[35]	Daruwala, R., Song, J., Koh, W.S., Rumsey, S.C. and Levine, M. (1999) Cloning and functional characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2. FEBS Letters, 460, 480-484.
[36]	Faaland, C.A., Race, J.E., Ricken, G., Warner, F.J., Williams, W.J. and Holtzman, E.J. (1998) Molecular characterization of two novel transporters from human and mouse kidney and from LLC-PK1 cells reveals a novel conserved family that is homologous to bacterial and Aspergillus nucleobase transporters. Biochimica et Biophysica Acta, 1442, 353-360.
[37]	Tsukaguchi, H., Tokui, T., Mackenzie, B., Berger, U.V., Chen, X.Z., Wang, Y., Brubaker, R.F. and Hediger, M.A. (1999) A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature, 399, 70-75.
[38]	Wang, H., Dutta, B., Huang, W., Devoe, L.D., Leibach, F.H., Ganapathy, V. and Prasad, P.D. (1999) Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant. Biochimica et Biophysica Acta, 1461, 1-9.
[39]	Wang, Y., Mackenzie, B., Tsukaguchi, H., Weremowicz, S., Morton, C.C. and Hediger, M.A. (2000) Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochemical and Biophysical Research Communications, 267, 488- 494.
[40]	Maulen, N.P., Henriquez, E.A., Kempe, S., Carcamo, J.G., Schmid-Kotsas, A., Bachem, M., Grunert, A., Bustamante, M.E., Nualart, F. and Vera, J.C. (2003) Up-regulation and polarized expression of the sodium-ascorbic acid transporter SVCT1 in post-confluent differentiated CaCo-2 cells. The Journal of Biological Chemistry, 278, 9035-9041.
[41]	Liang, W.J., Johnson, D., Ma, L.S., Jarvis, S.M. and Wei-Jun, L. (2002) Regulation of the human vitamin C transporters expressed in COS-1 cells by protein kinase C [corrected]. American Journal of Physiology Cell Physiology, 283, C1696-1704.
[42]	Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. The Journal of Immunological Methods, 65, 55-63.
[43]	Watanabe, F.D., Mullon, C.J., Hewitt, W.R., Arkadopoulos, N., Kahaku, E., Eguchi, S., Khalili, T., Arnaout, W., Shackleton, C.R., Rozga, J., Solomon, B. and Demetriou, A.A. (1997) Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Annals of Surgery, 225, 484-491.
[44]	Detry, O., Arkadopoulos, N., Ting, P., Kahaku, E., Watanabe, F.D., Rozga, J. and Demetriou, A.A. (1999) Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Annals of Surgery, 65, 934-938.
[45]	Ellis, A.J., Hughes, R.D., Wendon, J.A., Dunne, J., Langley, P.G., Kelly, J.H., Gislason, G.T., Sussman, N.L. and Williams, R. (1996) Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology, 24, 1446-1451.